{
  "type": "ref",
  "text": "Also in the current study binding activity to the CD28RE/AP-1 sequence of the IL-2 promoter is evaluated.\n",
  "self": {
    "NER": {
      "answers": [
        "IL-2"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What promoter is being studied for binding activity?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "the current study binding activity",
        "the CD28RE/AP-1 sequence",
        "the IL-2 promoter"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is evaluated?",
          "What is binding activity evaluated to?",
          "What is binding activity evaluated to?"
        ]
      }
    }
  },
  "asked": {
    "What promoter did the CD28RE/AP-1 sequence bind to?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "IL-2",
        "answerability": 0.8457168340682983,
        "ground_truth": {
          "IL-2": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What type of T cells were tested for binding activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005413413047790527,
        "ground_truth": {
          "Jurkat": {
            "bertscore": 0.6695131063461304,
            "f1": 0
          }
        }
      }
    },
    "What was the binding activity of the CD28RE/AP-1 sequence to the IL-2": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.6594904661178589,
        "ground_truth": {
          "We": {
            "bertscore": 0.6054112315177917,
            "f1": 0
          }
        }
      }
    },
    "What did we evaluate in Jurkat T cells?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.014163017272949219,
        "ground_truth": {
          "the binding activity": {
            "bertscore": 0.6831846237182617,
            "f1": 0
          }
        }
      }
    },
    "What was used to evaluate the binding activity of IL-2?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.24563652276992798,
        "ground_truth": {
          "the CD28RE/AP-1 sequence": {
            "bertscore": 0.6045441031455994,
            "f1": 0
          }
        }
      }
    },
    "What did the CD28RE/AP-1 sequence binding activity test?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.08480018377304077,
        "ground_truth": {
          "the IL-2 promoter": {
            "bertscore": 0.6207425594329834,
            "f1": 0
          }
        }
      }
    },
    "What type of cells were tested for binding activity?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.008690953254699707,
        "ground_truth": {
          "Jurkat T cells": {
            "bertscore": 0.6308838725090027,
            "f1": 0
          }
        }
      }
    }
  }
}